Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

1.91
Delayed Data
As of Jul 01
 0.00 / 0.00%
Today’s Change
1.53
Today|||52-Week Range
3.65
+3.80%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues3.0M34.4M11.5M15.2M
 
 
 
 
 
Cost of Goods Sold1.3M4.5M1.9M5.9M
 
 
 
 
 
Depreciation And Amortization3.6M3.7M3.5M3.1M
 
 
 
 
 
 
Operating ExpensesGross Income-2.0M26.3M6.1M6.1M
 
 
 
 
 
General Expenses34.6M37.5M40.7M38.4M
 
 
 
 
 
Research And Development28.0M28.7M33.3M29.8M
 
 
 
 
 
Total Operating Expenses39.5M45.6M46.1M47.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-36.5M-11.2M-34.6M-32.3M
 
 
 
 
 
Extraordinary Charge-10.0K-1.0M-1.0M-1.0M
 
 
 
 
 
Interest Expense On Debt0.000.00674.0K4.9M
 
 
 
Other Expenses0.000.008.5M8.1M
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-36.5M-11.6M-27.8M-29.9M
 
 
 
 
 
Net Income-36.5M-11.6M-27.8M-29.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS84.6M90.8M92.4M92.9M
 
 
 
 
 
Shares To Calculate EPS Diluted84.6M90.8M92.4M92.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.43-$0.13-$0.30-$0.32
 
 
 
 
 
EPS Diluted-$0.43-$0.13-$0.30-$0.32
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account